QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors

The serine hydrolase family includes serine proteases. It is essential for hydrolyzing protein peptide bonds and breaking them. The urokinase-type plasminogen activator (uPA) selectively binds to the uPAR on numerous cell types, including cancer cells. Pericellular proteolysis of cell-bound proteins...

Full description

Bibliographic Details
Main Authors: Rahul D. Jawarkar, Magdi E.A. Zaki, Sami A. Al-Hussain, Abdullah Yahya Abdullah Alzahrani, Long Chiau Ming, Abdul Samad, Rahul G. Ingle, Suraj N. Mali
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Chemical Physics Impact
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667022424000884
_version_ 1797299675580071936
author Rahul D. Jawarkar
Magdi E.A. Zaki
Sami A. Al-Hussain
Abdullah Yahya Abdullah Alzahrani
Long Chiau Ming
Abdul Samad
Rahul G. Ingle
Suraj N. Mali
author_facet Rahul D. Jawarkar
Magdi E.A. Zaki
Sami A. Al-Hussain
Abdullah Yahya Abdullah Alzahrani
Long Chiau Ming
Abdul Samad
Rahul G. Ingle
Suraj N. Mali
author_sort Rahul D. Jawarkar
collection DOAJ
description The serine hydrolase family includes serine proteases. It is essential for hydrolyzing protein peptide bonds and breaking them. The urokinase-type plasminogen activator (uPA) selectively binds to the uPAR on numerous cell types, including cancer cells. Pericellular proteolysis of cell-bound proteins requires this interaction. High uPA and uPAR levels regularly worsen cancer prognoses. Thus, small chemical active-site inhibitors that block uPA may diminish cancer cell invasion and metastasis. In compliance with Organization for Economic Corporation and Development guidelines, this research performed a complete Quantitative structure activity relationship analysis of sulfonamide compounds as Urokinase-type Plasminogen Activator inhibitors. Py-Descriptors were used for this investigation. PyDescriptor uses PyMOL standards and idioms to calculate 11,145 simple molecular descriptors. This plugin calculates molecular descriptors irrespective of molecular representation properties like atom numbering or labelling, spatial reference frame, translational and rotational invariance, etc. The investigation sought to find essential and hidden structural characteristics that regulate sulfonamide-type drugs' Urokinase-type Plasminogen Activator Inhibitory action. Twenty-eight sulfonamide chemicals are used in the Quantitative structure activity relationship study to generate statistically robust and highly predictive univariate and multivariate models. All models were thoroughly evaluated and meet several statistical parameter thresholds (e.g., R2 =0.9259–0.9280, Q2Loo= 0.8579–0.8558, Q2LMO= 0.8013–0.7865). The analysis reveal that occurance of ring carbon atoms exactly at 3 A0 from carbon atom, number of negatively charged atoms from sulphur atoms within 5 bonds, presence of hydrogen atom exactly at 3 bonds from donar atoms, presence of carbon atom exactly at 4 A0 from donar atom, presence of acceptor atom exactly at 5 A0 from sulphur atom and sum of partial charges of lipo atoms within 6 bonds from sulphur atom are important pharmacophoric features for Urokinase-type Plasminogen Activator Inhibition binding affinity. Thus, the developed Quantitative structure activity relationship study has an equilibrium of quantitative and qualitative tactics. The results could be useful for future optimizations of sulfonamide analogues.
first_indexed 2024-03-07T22:53:09Z
format Article
id doaj.art-3ca40588721f47c998ac1efe5db145bc
institution Directory Open Access Journal
issn 2667-0224
language English
last_indexed 2024-03-07T22:53:09Z
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Chemical Physics Impact
spelling doaj.art-3ca40588721f47c998ac1efe5db145bc2024-02-23T05:00:57ZengElsevierChemical Physics Impact2667-02242024-06-018100544QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitorsRahul D. Jawarkar0Magdi E.A. Zaki1Sami A. Al-Hussain2Abdullah Yahya Abdullah Alzahrani3Long Chiau Ming4Abdul Samad5Rahul G. Ingle6Suraj N. Mali7Department of Medicinal Chemistry, Dr. Rajendra Gode Institute of Pharmacy, University-Mardi Road, Amravati, India; Corresponding authors.Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia; Corresponding authors.Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi ArabiaDepartment of Chemistry, Faculty of Science and Arts, King Khalid University, Mohail Assir, Saudi ArabiaSchool of Medical and Life Sciences, Sunway University, Sunway City, MalaysiaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Tishk International University, Erbil, IraqDatta Meghe College of Pharmacy, DMIHER Deemed University, Wardha, IndiaDepartment of Pharmaceutical Chemistry, School of Pharmacy, D.Y. Patil University (Deemed to be University), Sector 7, Nerul, Navi Mumbai 400706, India; Corresponding authors.The serine hydrolase family includes serine proteases. It is essential for hydrolyzing protein peptide bonds and breaking them. The urokinase-type plasminogen activator (uPA) selectively binds to the uPAR on numerous cell types, including cancer cells. Pericellular proteolysis of cell-bound proteins requires this interaction. High uPA and uPAR levels regularly worsen cancer prognoses. Thus, small chemical active-site inhibitors that block uPA may diminish cancer cell invasion and metastasis. In compliance with Organization for Economic Corporation and Development guidelines, this research performed a complete Quantitative structure activity relationship analysis of sulfonamide compounds as Urokinase-type Plasminogen Activator inhibitors. Py-Descriptors were used for this investigation. PyDescriptor uses PyMOL standards and idioms to calculate 11,145 simple molecular descriptors. This plugin calculates molecular descriptors irrespective of molecular representation properties like atom numbering or labelling, spatial reference frame, translational and rotational invariance, etc. The investigation sought to find essential and hidden structural characteristics that regulate sulfonamide-type drugs' Urokinase-type Plasminogen Activator Inhibitory action. Twenty-eight sulfonamide chemicals are used in the Quantitative structure activity relationship study to generate statistically robust and highly predictive univariate and multivariate models. All models were thoroughly evaluated and meet several statistical parameter thresholds (e.g., R2 =0.9259–0.9280, Q2Loo= 0.8579–0.8558, Q2LMO= 0.8013–0.7865). The analysis reveal that occurance of ring carbon atoms exactly at 3 A0 from carbon atom, number of negatively charged atoms from sulphur atoms within 5 bonds, presence of hydrogen atom exactly at 3 bonds from donar atoms, presence of carbon atom exactly at 4 A0 from donar atom, presence of acceptor atom exactly at 5 A0 from sulphur atom and sum of partial charges of lipo atoms within 6 bonds from sulphur atom are important pharmacophoric features for Urokinase-type Plasminogen Activator Inhibition binding affinity. Thus, the developed Quantitative structure activity relationship study has an equilibrium of quantitative and qualitative tactics. The results could be useful for future optimizations of sulfonamide analogues.http://www.sciencedirect.com/science/article/pii/S2667022424000884Urokinase-type plasminogen activator inhibitorsQSARPharmacophoric features
spellingShingle Rahul D. Jawarkar
Magdi E.A. Zaki
Sami A. Al-Hussain
Abdullah Yahya Abdullah Alzahrani
Long Chiau Ming
Abdul Samad
Rahul G. Ingle
Suraj N. Mali
QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
Chemical Physics Impact
Urokinase-type plasminogen activator inhibitors
QSAR
Pharmacophoric features
title QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
title_full QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
title_fullStr QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
title_full_unstemmed QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
title_short QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
title_sort qsar modelling to predict structural features of certain sulfonamide as urokinase type plasminogen activator inhibitors
topic Urokinase-type plasminogen activator inhibitors
QSAR
Pharmacophoric features
url http://www.sciencedirect.com/science/article/pii/S2667022424000884
work_keys_str_mv AT rahuldjawarkar qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT magdieazaki qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT samiaalhussain qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT abdullahyahyaabdullahalzahrani qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT longchiauming qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT abdulsamad qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT rahulgingle qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors
AT surajnmali qsarmodellingtopredictstructuralfeaturesofcertainsulfonamideasurokinasetypeplasminogenactivatorinhibitors